XBiotech Inc.
XBIT
$2.92
-$0.06-2.01%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -2.75% | 17.61% | 1.09% | -8.76% | -2.26% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.88% | 9.58% | 13.23% | 13.17% | 16.22% |
| Operating Income | 14.88% | -9.58% | -13.23% | -14.09% | -22.81% |
| Income Before Tax | 19.14% | -29.58% | -58.60% | -47.48% | -36.97% |
| Income Tax Expenses | -88.04% | -109.18% | -113.17% | -109.78% | -93.06% |
| Earnings from Continuing Operations | 19.55% | -28.20% | -56.90% | -41.22% | -23.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 19.55% | -28.20% | -56.90% | -41.22% | -23.18% |
| EBIT | 14.88% | -9.58% | -13.23% | -14.09% | -22.81% |
| EBITDA | 15.57% | -9.95% | -13.87% | -14.83% | -25.21% |
| EPS Basic | 19.62% | -28.08% | -56.79% | -41.16% | -23.15% |
| Normalized Basic EPS | 19.22% | -29.46% | -58.51% | -47.42% | -36.94% |
| EPS Diluted | 19.85% | -27.33% | -55.63% | -41.06% | -23.12% |
| Normalized Diluted EPS | 19.22% | -29.46% | -58.51% | -47.42% | -36.94% |
| Average Basic Shares Outstanding | 0.11% | 0.10% | 0.07% | 0.05% | 0.02% |
| Average Diluted Shares Outstanding | 0.11% | 0.10% | 0.07% | 0.05% | 0.02% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |